Publication | Closed Access
Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children
139
Citations
27
References
2013
Year
The QIV was efficacious in preventing influenza in children. (Funded by GlaxoSmithKline Biologicals; ClinicalTrials.gov number, NCT01218308.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1